Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3593]

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

Ground-breaking trial of CRISPR-edited immune cells for cancer appears safe

To monitor cancer therapy, researchers tag CAR T cells with imaging markers

To monitor cancer therapy, researchers tag CAR T cells with imaging markers

Researchers identify a mechanism controlling tumour cell recognition by immune cells

Researchers identify a mechanism controlling tumour cell recognition by immune cells

$Antibody-drug conjugate shows early promise in patients with relapsed/refractory B-cell non-hodgkin lymphoma$

Antibody-drug conjugate shows early promise in patients with relapsed/refractory B-cell non-hodgkin lymphoma

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

Dynamic transition of the blood-brain barrier in the development of NSCLC brain metastases

Dynamic transition of the blood-brain barrier in the development of NSCLC brain metastases

Enter the exosome: How cancer and immune cells communicate

Enter the exosome: How cancer and immune cells communicate

Clinical trial reduces relapse in paediatric ALL patients

Clinical trial reduces relapse in paediatric ALL patients

European Commission approves avelumab plus axitinib for first-line advanced renal cell carcinoma

European Commission approves avelumab plus axitinib for first-line advanced renal cell carcinoma

Prize awarded for the further development of cellular immunotherapies

Prize awarded for the further development of cellular immunotherapies

More from ecancer